Professor Andrea Brancale
Projects as PI
1 of 12
- ADC targets from in-silico high throughput screening identification into target validation (01/10/2016 - 21/02/2019)
- ADME/toxicology analyses of lead Schistosoma mansoni histone methyltransferase (HMT) inhibitors (30/06/2018 - 21/02/2019)
- Advanced Therapeutics Wales (01/07/2018 - 21/02/2019)
- All Wales antivirals discovery and development platform (01/01/2016 - 31/03/2019)
- An event to explore Intellectual Property Rights (01/01/2018 - 04/01/2019)
Projects as Co-Investigator
9 of 9
- Sustained release formulations for new drugs in the treatment of mitochondrial optic neuropathies (01/02/2020 - 11/02/2022)
- Synthesis of novel indole derivatives as apoptosis-inducing antitumour agents (01/01/2007 - 01/01/2010)
- Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development (01/07/2014 - 31/01/2016)
- The identification and selection of candidate lead compounds against BCL3 (01/11/2013 - 13/10/2017)
- Vector-borne emerging diseases: Computer-aided design, synthesis and evaluation of novel antiviral compounds against Chikungunya and Zika viruses (01/12/2016 - 30/11/2019)
